A Double-Blind, Placebo-Controlled Study of Cariprazine as an Adjunct to Antidepressants in the Treatment of Patients With Major Depressive Disorder Who Have Had an Inadequate Response to Antidepressants Alone
A Double-Blind, Placebo-Controlled Study of Cariprazine as an Adjunct to Antidepressants in the Treatment of Patients With Major Depressive Disorder Who Have Had an Inadequate Response to Antidepressants Alone
The objective of this study is to evaluate the efficacy, safety and tolerability of cariprazine as an adjunctive treatment to antidepressant therapy (ADT) in patients with MDD who have had an inadequate response to antidepressants alone.
Inclusion Criteria:
Exclusion Criteria:
Anaheim, California 92804-3738, United States
Garden Grove, California 92845, United States
Winfield, Illinois 60190, United States
Portland, Oregon 97214-2569, United States
Woodstock, Vermont 05091, United States
Sofiya, Sofia 1431, Bulgaria
Kalocsa, Bács-Kiskun county 6300, Hungary
Budapest, Pest County 1036, Hungary
Kryvbas Village, Dnipropetrovsk Oblast 53054, Ukraine
Ivano-Frankivsk, Ivano-Frankivsk Oblast 76014, Ukraine
Kharkiv, Kharkiv Oblast 61068, Ukraine
Kharkiv, Kharkiv Oblast 61068, Ukraine
Kharkiv, Kharkiv Oblast 61068, Ukraine
Stepanivka Village, Kherson Oblast 73488, Ukraine
Oleksandrivka Village, Odesa Oblast 67513, Ukraine
Uzhhorod, Zakarpattia Oblast 88000, Ukraine
Chertsey, Surrey KT16 0AE, United Kingdom